Clinical and Biological Analysis of Peripheral T-Cell Lymphomas: A Single Institution Study

References

• Horning S. J., Weiss L. M., Crabtree G. S., Warnke R. A. Clinical and phenotypic diversity of T cell lymphomas. Blood 1986; 67: 1578–82
   PubMed Web of Science ®Google Scholar
• Armitage J. O., Greer J. P., Levine A. M., Weisenburger D. D., Formenti S. C., Bast M., Conley S., Pierson J., Linder J., Cousar J. B., Nathwani B. N. Peripheral T-cell lymphoma. Cancer 1989; 63: 158–63
   PubMed Web of Science ®Google Scholar
• Coiffler B., Berger F., Bryon P. A., Magaud J. P. T-cell lymphomas: immunologic, histologic, clinical and therapeutic analysis of 63 cases. J. Clin. Oncol 1988; 6: 1584–89
   PubMed Web of Science ®Google Scholar
• Coiffier B., Brousse N., Peuchmaur M., Berger F., Gisselbrecht C., Bryon P. A., Diebold J. Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. Annals of Oncology 1990; 45–50
   PubMed Web of Science ®Google Scholar
• Greer J. P., York J. C., Cousar J. B., Mitchell R. T., Flexner J. M., Collins R. D., Stein R. S. Peripheral T-cell lymphoma: a clinicopathologic study of 42 cases. J. Clin. Oncol 1984; 7: 788–98
   Google Scholar
• Weisenburger D. D., Astorino R. N., Glassy F. J., Miller C. H., MacKenzie M. R., Caggiano V. Peripheral T-cell lymphoma. A clinicopathologic study of morphologically diverse entity. Cancer 1985; 56: 2061–68
   PubMed Web of Science ®Google Scholar
• Weis J. W., Winter M. W., Phyliky R. L., Banks P. M. Peripheral T-cell lumphomas: histologic, immunohisto-logic and clinical characterization. Mayo Clin. Proc 1986; 61: 411–26
   PubMed Web of Science ®Google Scholar
• Brisbane J. U., Berman L. D., Neiman R. S. Peripheral T-cell lymphoma. A clinicopathologic study of nine cases. Am. J. Pathol 1983; 79: 285–93
   Web of Science ®Google Scholar
• Cossman J., Jaffe E. S., Fisher R. I. Immunologic phenotypes of diffuse aggressive non-Hodgkin's lymphomas. Correlation with clinical features. Cancer 1984; 54: 1310–17
   PubMed Web of Science ®Google Scholar
• Henni T., Gaulard P., Divine M., Le Couedic J. P., Rocha D., Haioun C., Henni Z., Marolleau J. P., Pinaudeau Y., Goossens M., Farcet J. P., Reyes F. Comparison of genetic probe with immunophenotype analysis in lympho-proliferative disorders: a study of 87 cases. Blood 1988; 72: 1937–43
   PubMed Web of Science ®Google Scholar
• Armitage J. O., Vose J. M., Linder J., Weisenburger D., Harrington D., Casey J., Bierman P., Sorensen S., Hutchins M., Moravec D. F., Howe D., Dowling M. D., Mailliard J., Johnson P. S., Pevnick W., Packard W. M., Okerbloom J., Thompson R. F., Langdon R. M., Soori G., Peterson C., Purtilo D. Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma. J. Clin. Oncol 1989; 7: 1783–90
   PubMed Web of Science ®Google Scholar
• Cheng A. L., Chen Y. C., Wang C. H., Su I. J., Hsieh H. C., Chang J. Y., Hwang W. S., Su W. C., Liu T. W., Tien H. F., Tsai W., Shen M. C., Liu C. H. Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades — Should peripheral T-cell lymphoma be considered separately?. J. Clin. Oncol 1989; 7: 725
   PubMed Web of Science ®Google Scholar
• Lippman S., Miller M., Spier T. P., Slymen C. M., Grogan T. M. The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype. Blood 1988; 11: 436–41
   Google Scholar
• The non-Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas Summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112–35
   PubMed Web of Science ®Google Scholar
• Diebold J., Stansfeld A. G., Kapanci Y., Kelenyi G., Lennert K., Mioduszewska O., Noel H., Rilke F., Sundstrom C., Van Unnik J. A. M., Wright D. H. Updated kiel classification of non-Hodgkin's lymphomas. Lancet 1988; 292–93
   PubMed Web of Science ®Google Scholar
• Watanabe S., Nakajima T., Shimosato Y., Shimoyama M., Minato K. T-cell malignancies sub-classification and interrelationship. Jpn. J. Clin. Oncol. 1979; 9: 432–42
   Google Scholar
• Gaulard P., Bourquelot P., Kanavaros P., Haioun C., Le Couedic J. P., Divine M., Goossens M., Zafrani E. S., Farcet J. P., Reyes F. Expression of the α/β and γ/δ T-cell receptors in 57 cases of peripheral T-cell lymphomas. Am. J. Pathol 1990; 137: 617–28
   PubMed Web of Science ®Google Scholar
• Farcet J. P., Gaulard P., Marolleau J. P., Le Couedic J. P., Henni T., Gourdin M. F., Divine M., Haioun C., Zafrani E. S., Goossens M., Hercend T., Reyes F. Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor γδ. Blood 1990; 75: 1–7
   PubMedGoogle Scholar
• Coiffier B., Bryon P. A., Ffrench M., Blanc M., Sebban C., Berger F., Viala J. J. Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80). J. Clin. Oncol. 1986; 4: 147–53
   PubMed Web of Science ®Google Scholar
• Kaplan E. L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc 1958; 53: 157–81
   Web of Science ®Google Scholar
• Picker L. J., Weiss L. M., Medeiros L. J., Wood G. S., Warnke R. A. Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. Am. J. Pathol. 1987; 128: 181–201
   PubMed Web of Science ®Google Scholar
• Picker L. J., Brenner M. B., Weiss L. M., Smith S. D., Warnke R. A. Discordant expression of CD3 and T-cell receptor /3-chain antigens in T-lineage lymphomas. Am. J. Pathol. 1987; 129: 434–40
   PubMed Web of Science ®Google Scholar
• Ng C. S., Chan J. K. C., Hui P. K., Chang W. C., Lo S. T. H. Application of T-cell receptor antibody βF1 for immunophenotypic analysis of malignant lymphomas. Am. J. Pathol 1988; 132: 365–71
   PubMed Web of Science ®Google Scholar
• D'Agay M. F., Gaulard P., Berger F., Lepage E., Bosly A., Coiffier B., Gisselbrecht C., Reyes F., Tilly H., Mason D., Diebold J. Histological and immunological study of 1200 cases of aggressive lymphomas included in the GELA protocol. Fourth International Conference on Malignant Lymphoma, Lugano, June, 1990, 6–9
   Google Scholar
• Coiffier B., Gisselbrecht C., Herbrecht R., Tilly H., Bosly A., Brousse N. LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. J. Clin. Oncol 1989; 7: 1018–26
   PubMed Web of Science ®Google Scholar
• Vose J. M., Peterson C., Bierman P. J., Weisenburger D. D., Linder J., Harrington D., Vaughan W. P., Kessinger A., Armitage J. O. Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas. Blood 1990; 76: 424–31
   PubMed Web of Science ®Google Scholar